Journal of Clinical Pharmacy and Therapeutics

Volume 23, Issue 4 pp. 243-246

The glutamate hypothesis of schizophrenia

Akhondzadeh, 

Akhondzadeh

Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Iran

Search for more papers by this author

Akhondzadeh, 

Akhondzadeh

Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Iran

Search for more papers by this author

First published: 09 October 2008

https://doi.org/10.1046/j.1365-2710.1998.00160.x

Citations: 13

Dr ShahinAkhondzadeh No. 29, 39th Street, Gisha Street, Tehran 14479, Iran. Fax:+21-93-32-22. E-mail: [email protected]

References

• 1 JablenskyA, SartoriusN, ErnbergG1991Schizophrenia: manifestation, incidence and course in different cultures. A World Health Organization ten-country studyPsychological Medicine 20(Suppl.) 1 97
  Google Scholar
• 2 BaronM, GruenR, RainerJD1985A family study of schizophrenic and normal control probands: implications for the spectrum concept of schizophreniaAmerican Journal of Psychiatry 142 447 455
  10.1176/ajp.142.4.447

  CAS PubMed Web of Science® Google Scholar
• 3 KendlerKs & DiehlSR1993The genetics of schizophrenia: a current genetic-epidemiologic perspectiveSchizophrenia Bulletin 19 261 285
  10.1093/schbul/19.2.261

  PubMed Web of Science® Google Scholar
• 4 HeymanI & MurrayRM1992Schizophrenia and neuro?developmentJournal of Royal College of Physicians London 26 143 146
  CAS PubMed Web of Science® Google Scholar
• 5 BogertsB1993Recent advances in the neuropathology of schizophreniaSchizophrenia Bulletin 19 431 445
  10.1093/schbul/19.2.431

  CAS PubMed Web of Science® Google Scholar
• 6 DenikerP1970 Introduction of neuroleptic chemotherapy into psychiatry. In: Ayd F, Balckwell B. (eds) Discoveries in Biological Psychiatry. Philadelphia: JB Lippincott Company 155 164
  Google Scholar
• 7 SnyderS1976The dopamine hypothesis in schizophrenia: focus on the dopamine receptorAmerican Journal of Psychiatry 133 197 202
  10.1176/ajp.133.2.197

  CAS PubMed Web of Science® Google Scholar
• 8 AngristB, RotrosenJ, GershonS1980Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophreniaPsychopharmacology 72 17 19
  10.1007/BF00433802

  CAS PubMed Web of Science® Google Scholar
• 9 SeidenL & SabolK1993Amphetamine: effects on catechol?amine systems and behaviorAnnals of Review of Pharmacology and Toxicology 32 639 677
  CAS Web of Science® Google Scholar
• 10 JohnstoneE, CrowT, FrithC1978Mechanism of antipsychotic effect in the treatment of acute schizophreniaLancet I 848 851
  10.1016/S0140-6736(78)90193-9

  CAS Google Scholar
• 11 MeltzerHY, LeeMA, RanjanR1994Recent advances in the pharmacotherapy of schizophreniaActa Psychiatry Scandinavian 90(Suppl. 384) 95 101
  Google Scholar
• 12 MeltzerHY & SommersAA1986The effect of neuroleptics and other psychotropic drug on negative symptoms in schizophreniaJournal of Clinical Psychopharmacology 6 329 338
  10.1097/00004714-198612000-00002

  PubMed Web of Science® Google Scholar
• 13 MorrisonRL & BellackAS1987Social functioning of schizophrenic patients: clinical and research issuesSchizophrenia Bulletin 13 715 725
  10.1093/schbul/13.4.715

  PubMed Web of Science® Google Scholar
• 14 GraceAA1991Phasic nervous tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophreniaNeuroscience 41 1 24
  10.1016/0306-4522(91)90196-U

  CAS PubMed Web of Science® Google Scholar
• 15 AtmmingaCA, CascellaN, FakouhiTD, HertingRL1992 Enhancement of NMDA-mediated transmission in schizophrenia. Effects of milacemide. In: Meltzer HY. (ed.) Novel Antipsychotic Drugs. New York: Raven Press Ltd 171 177
  Google Scholar
• 16 KimJS, KornhberHH, Schmid-BurgkW, HolzmullerB1980Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophreniaNeuroscience Letter 20 379 382
  10.1016/0304-3940(80)90178-0

  CAS PubMed Web of Science® Google Scholar
• 17 FonnumF1984Glutamate: a neurotransmitter in mammalian brainJournal of Neurochemistry 42 1 11
  10.1111/j.1471-4159.1984.tb09689.x

  CAS PubMed Web of Science® Google Scholar
• 18 CollingridgeGL & LesterR1989Excitatory amino acid receptors in the vertebrate central nervous systemPharmacology Review 40 143 210
  Google Scholar
• 19 MonaghanDT, BridgesRJ, CotmanCW1989The excitatory amino acid receptors: their classes, pharmacology and distinct properties in the function of the central nervous systemAnnual Review of Pharmacology and Toxicology 29 365 402
  10.1146/annurev.pa.29.040189.002053

  CAS PubMed Web of Science® Google Scholar
• 20 NakanishiS1992Molecular diversity of glutamate receptors and implication for brain functionScience 258 597 603
  10.1126/science.1329206

  CAS PubMed Web of Science® Google Scholar
• 21 MillerRJ1991Metabotropic excitatory amino acid receptors reveal their true colorsTrends in Pharmacological Science 12 365 367
  10.1016/0165-6147(91)90604-Q

  CAS PubMed Web of Science® Google Scholar
• 22 DrejerJ, LarssonOM, SchousboeA1982Characterization of l-glutamate uptake into and release from astrocytes and neurons cultured from different brain regions Experimental Brain Research 47 259 269
  10.1007/BF00239385

  CAS PubMed Web of Science® Google Scholar
• 23 LodgeD & JohnsonKM1990Non-competitive excitatory amino acid receptor antagonistsTrends in Pharmacological Science 11 81 88
  10.1016/0165-6147(90)90323-Z

  CAS PubMed Web of Science® Google Scholar
• 24 JavittDC & ZukinSR1991Recent advances in the phencyclidine model of schizophreniaAmerican Journal of Psychiatry 148 1301 1308
  10.1176/ajp.148.10.1301

  CAS PubMed Web of Science® Google Scholar
• 25 KrystalJH, KarperLP, SebylJP1994Subanesthetic effects of noncompetitive NMDA antagonist, Ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses.Archives of General Psychiatry 51 199 214
  10.1001/archpsyc.1994.03950030035004

  CAS PubMed Web of Science® Google Scholar
• 26 HarrisonPJ, MclaghlinD, KerwinRW1991Decreased hippocampal expression of a glutamate receptor gene in schizophreniaLancet 337 450 452
  10.1016/0140-6736(91)93392-M

  PubMed Web of Science® Google Scholar
• 27 UlasJ & CotmanC1993Excitatory amino acid receptors in schizophreniaSchizophrenia Bulletin 19 105 117
  10.1093/schbul/19.1.105

  CAS PubMed Web of Science® Google Scholar
• 28 LawlorBA & DavisKL1992Does modulation of glutamatergic function represent a viable therapeutic strategy in Alzheimer's disease?Biological Psychiatry 31 337 350
  10.1016/0006-3223(92)90227-Q

  CAS PubMed Web of Science® Google Scholar
• 29 ThomasJW, HoodWF, MonahanJB, ContrerasPC, O’DonohueTL1988Glycine modulation of phencyclidine binding site in mammalian brainBrain Research 442 396 398
  10.1016/0006-8993(88)91533-8

  CAS PubMed Web of Science® Google Scholar
• 30 RosseRB, SchwartzBL, DavisRE, DeutschSI1991An NMDA intervention strategy in schizophrenia with low dose milacemideClinical Neuropharmacology 14 268 272
  10.1097/00002826-199106000-00012

  CAS PubMed Web of Science® Google Scholar
• 31 ChesselI, ProcterA, FrancisP, BowenD1991d -Cycloserine, a putative cognitive enhancer, facilitates activation of the N-methyl- d -aspartate receptor–ionophore complex in Alzheimer brain Brain Research 565 345 348
  10.1016/0006-8993(91)91668-Q

  CAS PubMed Web of Science® Google Scholar
• 32 RowlandsGC & RobertsPJ1980Activation of dopamine receptors inhibits calcium-dependent glutamate release from cortico-striatal terminals in vitroEuropean Journal of Pharmacology 62 241 247
  10.1016/0014-2999(80)90285-X

  CAS PubMed Web of Science® Google Scholar
• 33 MauraG, BarzizzaA, LotteroP, RaiteriM1990The excitatory amino acid-releasing nerve terminals in rat striatum possess D-2 dopamine receptors mediating inhibition of releaseNeurochemistry International 16(Suppl. 1) 53
  Google Scholar
• 34 WolkowitzOM & PickarD1991Benzodiazepines in the treatment of schizophrenia: a review and reappraisalAmerican Journal of Psychiatry 148 714 726
  10.1176/ajp.148.6.714

  CAS PubMed Web of Science® Google Scholar
• 35 WhitingPJ, McKernanRM, WaffordKA1995Structure and pharmacology of vertebrate GABA_A receptor subtypesInternational Review of Neurobiology 38 95 138
  10.1016/S0074-7742(08)60525-5

  CAS PubMed Web of Science® Google Scholar

Citing Literature

• 
  All articles  >

• References

• Related

• Information

Close Figure Viewer

Previous FigureNext Figure

Caption

Download PDF